Mitochondrial respiratory chain and Krebs cycle enzyme function in human donor livers subjected to end-ischaemic hypothermic machine perfusion

• Published in: PloS one 2021-10, Vol.16 (10), p.e0257783-e0257783
• Main Authors: Abudhaise, Hamid, Taanman, Jan-Willem, DeMuylder, Peter, Fuller, Barry, Davidson, Brian R
• Format: Article
• Language: English
• Subjects: Analysis; Biology and Life Sciences; Biomarkers; Blood & organ donations; Chains; Citrate synthase; Cold storage; Cryopreservation; Electron transport chain; Enzymatic activity; Enzyme activity; Enzymes; Function analysis; Hepatic artery; Ischemia; Krebs cycle; Liver; Liver transplants; Medicine and Health Sciences; Mitochondria; Mitochondrial diseases; Oxygen; Oxygenation; Perfusion; Phosphorylation; Physical Sciences; Portal vein; Reperfusion; Reperfusion injury; Respiration; Respiratory function; Risk; Risk factors; Steatosis; Surgery; Transplantation; Transplants & implants; Tricarboxylic acid cycle; Work stations
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0257783

Marginal human donor livers are highly susceptible to ischaemia reperfusion injury and mitochondrial dysfunction. Oxygenation during hypothermic machine perfusion (HMP) was proposed to protect the mitochondria but the mechanism is unclear. Additionally, the distribution and uptake of perfusate oxygen during HMP are unknown. This study aimed to examine the feasibility of mitochondrial function analysis during end-ischaemic HMP, assess potential mitochondrial viability biomarkers, and record oxygenation kinetics. This was a randomised pilot study using human livers retrieved for transplant but not utilised. Livers (n = 38) were randomised at stage 1 into static cold storage (n = 6), hepatic artery HMP (n = 7), and non-oxygen supplemented portal vein HMP (n = 7) and at stage 2 into oxygen supplemented and non-oxygen supplemented portal vein HMP (n = 11 and 7, respectively). Mitochondrial parameters were compared between the groups and between low- and high-risk marginal livers based on donor history, organ steatosis and preservation period. The oxygen delivery efficiency was assessed in additional 6 livers using real-time measurements of perfusate and parenchymal oxygen. The change in mitochondrial respiratory chain (complex I, II, III, IV) and Krebs cycle enzyme activity (aconitase, citrate synthase) before and after 4-hour preservation was not different between groups in both study stages (p > 0.05). Low-risk livers that could have been used clinically (n = 8) had lower complex II-III activities after 4-hour perfusion, compared with high-risk livers (73 nmol/mg/min vs. 113 nmol/mg/min, p = 0.01). Parenchymal pO.sub.2 was consistently lower than perfusate pO.sub.2 (p [less than or equal to] 0.001), stabilised in 28 minutes compared to 3 minutes in perfusate (p = 0.003), and decreased faster upon oxygen cessation (75 vs. 36 minutes, p = 0.003). Actively oxygenated and air-equilibrated end-ischaemic HMP did not induce oxidative damage of aconitase, and respiratory chain complexes remained intact. Mitochondria likely respond to variable perfusate oxygen levels by adapting their respiratory function during end-ischaemic HMP. Complex II-III activities should be further investigated as viability biomarkers.